Healthcare provider profile · identity verified

Malalai Azmi, MD

Family Practice · STONY CREEK, VA · NPI 1891766549

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	451	125
Atorvastatin Calcium	Atorvastatin Calcium	369	93
Omeprazole	Omeprazole	240	57
Losartan Potassium	Losartan Potassium	232	55
Metoprolol Succinate	Metoprolol Succinate	201	54
Lisinopril	Lisinopril	195	48
Levothyroxine Sodium	Levothyroxine Sodium	172	39
Hydrochlorothiazide	Hydrochlorothiazide	170	41
Metformin Hcl	Metformin Hcl	163	40
Pantoprazole Sodium	Pantoprazole Sodium	149	37
Rosuvastatin Calcium	Rosuvastatin Calcium	142	36
Furosemide	Furosemide	138	42
Hydralazine Hcl	Hydralazine Hcl	137	37
Potassium Chloride	Potassium Chloride	136	33
Gabapentin	Gabapentin	134	35
Methylprednisolone	Methylprednisolone	125	96
Azithromycin	Azithromycin	124	104
Albuterol Sulfate Hfa	Albuterol Sulfate	119	47
Jardiance	Empagliflozin	119	32
Metformin Hcl Er	Metformin Hcl	117	36
Escitalopram Oxalate	Escitalopram Oxalate	100	25
Carvedilol	Carvedilol	99	25
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	79	20
Pravastatin Sodium	Pravastatin Sodium	78	18
Atenolol	Atenolol	75	14
Tamsulosin Hcl	Tamsulosin Hcl	72	20
Ozempic	Semaglutide	71	12
Sertraline Hcl	Sertraline Hcl	70	19
Simvastatin	Simvastatin	69	18
Metoprolol Tartrate	Metoprolol Tartrate	66	20
Montelukast Sodium	Montelukast Sodium	65	19
Eliquis	Apixaban	63	16
Amoxicillin	Amoxicillin	62	49
Dropsafe Prep Pads	Alcohol Antiseptic Pads	62	18
Glipizide	Glipizide	62	17
Clonidine Hcl	Clonidine Hcl	58	12
Glipizide Er	Glipizide	57	16
Prednisone	Prednisone	57	24
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	56	12
Ezetimibe	Ezetimibe	55	16
Diclofenac Sodium	Diclofenac Sodium	54	25
Bupropion Hcl Sr	Bupropion Hcl	53	suppressed
Trazodone Hcl	Trazodone Hcl	52	12
Allopurinol	Allopurinol	51	14
Isosorbide Mononitrate Er	Isosorbide Mononitrate	51	12
Shingrix	Varicella-Zoster Ge/As01b/Pf	51	41
Chlorthalidone	Chlorthalidone	50	suppressed
Clopidogrel	Clopidogrel Bisulfate	50	16
Clonazepam	Clonazepam	49	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	48	45
Januvia	Sitagliptin Phosphate	48	suppressed
Donepezil Hcl	Donepezil Hcl	46	suppressed
Fluticasone Propionate	Fluticasone Propionate	45	16
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	41	16
Hydroxyzine Hcl	Hydroxyzine Hcl	38	13
Spironolactone	Spironolactone	38	13
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	35	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	34	25
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	32	suppressed
Synthroid	Levothyroxine Sodium	32	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	30	suppressed
Mirtazapine	Mirtazapine	30	suppressed
Irbesartan	Irbesartan	29	suppressed
Nifedipine Er	Nifedipine	29	suppressed
Paroxetine Hcl	Paroxetine Hcl	29	suppressed
Xarelto	Rivaroxaban	29	suppressed
Buspirone Hcl	Buspirone Hcl	27	suppressed
Fluconazole	Fluconazole	27	23
Citalopram Hbr	Citalopram Hydrobromide	26	suppressed
Bupropion Xl	Bupropion Hcl	25	suppressed
Meloxicam	Meloxicam	25	suppressed
Symbicort	Budesonide/Formoterol Fumarate	25	11
Cephalexin	Cephalexin	24	23
Dexlansoprazole Dr	Dexlansoprazole	24	suppressed
Lorazepam	Lorazepam	24	suppressed
Tradjenta	Linagliptin	24	suppressed
Tramadol Hcl	Tramadol Hcl	24	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	23	suppressed
Levofloxacin	Levofloxacin	22	18
Famotidine	Famotidine	21	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	20	suppressed
Meclizine Hcl	Meclizine Hcl	20	suppressed
Ibuprofen	Ibuprofen	19	suppressed
Ropinirole Hcl	Ropinirole Hcl	19	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	19	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	18	suppressed
Valsartan	Valsartan	18	suppressed
Duloxetine Hcl	Duloxetine Hcl	17	suppressed
Glimepiride	Glimepiride	17	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	17	14
Celecoxib	Celecoxib	16	suppressed
Ipratropium Bromide	Ipratropium Bromide	16	suppressed
Naproxen	Naproxen	16	suppressed
Ondansetron Odt	Ondansetron	16	suppressed
Trulicity	Dulaglutide	16	suppressed
Breyna	Budesonide/Formoterol Fumarate	15	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	15	suppressed
Gemfibrozil	Gemfibrozil	15	suppressed
Linzess	Linaclotide	15	suppressed
Nystatin	Nystatin	15	13
Alprazolam	Alprazolam	14	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	14	14
Azelastine Hcl	Azelastine Hcl	14	suppressed
Farxiga	Dapagliflozin Propanediol	14	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	14	suppressed
Klor-Con M20	Potassium Chloride	14	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	13	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	13	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	13	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	12	suppressed
Colchicine	Colchicine	12	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	12	suppressed
Haloperidol Lactate	Haloperidol Lactate	12	suppressed
Lidocaine	Lidocaine	12	suppressed
Memantine Hcl	Memantine Hcl	12	suppressed
Mounjaro	Tirzepatide	12	suppressed
Olanzapine	Olanzapine	12	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	12	12
Propranolol Hcl	Propranolol Hcl	12	suppressed
Verapamil Er	Verapamil Hcl	12	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	12	suppressed
Alendronate Sodium	Alendronate Sodium	11	suppressed
Labetalol Hcl	Labetalol Hcl	11	suppressed
Lovastatin	Lovastatin	11	suppressed
Mupirocin	Mupirocin	11	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	11	suppressed
Varenicline Tartrate	Varenicline Tartrate	11	suppressed
Vascepa	Icosapent Ethyl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error